103 related articles for article (PubMed ID: 9042407)
21. Increased resistance to the anticellular effect of interferon in an ultraviolet light-resistant human cell line, UVr-1.
Suzuki N; Watanabe I; Nishimaki J; Fuse A; Sugita K; Sekiya S; Takakubo Y; Terao K
J Gen Virol; 1986 Apr; 67 ( Pt 4)():651-61. PubMed ID: 3007659
[TBL] [Abstract][Full Text] [Related]
22. N-ras mutation in ultraviolet radiation-induced murine skin cancers.
Pierceall WE; Kripke ML; Ananthaswamy HN
Cancer Res; 1992 Jul; 52(14):3946-51. PubMed ID: 1617670
[TBL] [Abstract][Full Text] [Related]
23. Establishment and characterization of a human cell strain, KT, with high sensitivity to UV-killing and to cell proliferation inhibition by interferon.
Suzuki N; Inaba N; Sugano I; Umehara S; Murakami T; Takakubo Y
Jpn J Cancer Res; 1988 Nov; 79(11):1184-92. PubMed ID: 3147274
[TBL] [Abstract][Full Text] [Related]
24. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
[TBL] [Abstract][Full Text] [Related]
25. Activation of N-ras induced by ultraviolet irradiation in vitro.
Van der Lubbe JL; Rosdorff HJ; Bos JL; Van der Eb AJ
Oncogene Res; 1988; 3(1):9-20. PubMed ID: 3060800
[TBL] [Abstract][Full Text] [Related]
26. Frequent p53 alterations but low incidence of ras mutations in UV-B-induced skin tumors of hairless mice.
van Kranen HJ; de Gruijl FR; de Vries A; Sontag Y; Wester PW; Senden HC; Rozemuller E; van Kreijl CF
Carcinogenesis; 1995 May; 16(5):1141-7. PubMed ID: 7767977
[TBL] [Abstract][Full Text] [Related]
27. Supervision of cellular response to radiation by human interferon.
Suzuki N; Suzuki H
Acta Biol Hung; 1990; 41(1-3):243-8. PubMed ID: 2128791
[TBL] [Abstract][Full Text] [Related]
28. Human cell clones, RSa and UVr-1, differing in their capability for UV-induced virus reactivation and phenotypic mutation.
Suzuki N; Kimoto H; Koseki H; Miura N; Watanabe T; Inaba N; Takamizawa H; Hashizume S
Mutat Res; 1994 Apr; 306(2):211-22. PubMed ID: 7512221
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxicity of human beta-interferon for differentiating leukemic HL-60 cells.
Hamburger AW; White CP; Siebenlist RE; Sedmak JJ; Grossberg SE
Cancer Res; 1985 Nov; 45(11 Pt 1):5369-73. PubMed ID: 2996760
[TBL] [Abstract][Full Text] [Related]
30. Relationship between the formation of promutagenic adducts and the activation of the K-ras protooncogene in lung tumors from A/J mice treated with nitrosamines.
Belinsky SA; Devereux TR; Maronpot RR; Stoner GD; Anderson MW
Cancer Res; 1989 Oct; 49(19):5305-11. PubMed ID: 2670201
[TBL] [Abstract][Full Text] [Related]
31. Modulation of cell mutability by serum factors from volunteers who experienced head-down-tilt bed rest.
Sugaya S; Kita K; Fukuoka H; Suzuki N
Biol Sci Space; 2004 Nov; 18(3):167-8. PubMed ID: 15858374
[TBL] [Abstract][Full Text] [Related]
32. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
Goodrow T; Reynolds S; Maronpot R; Anderson M
Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
[TBL] [Abstract][Full Text] [Related]
33. IFN-beta induces caspase-mediated apoptosis by disrupting mitochondria in human advanced stage colon cancer cell lines.
Juang SH; Wei SJ; Hung YM; Hsu CY; Yang DM; Liu KJ; Chen WS; Yang WK
J Interferon Cytokine Res; 2004 Apr; 24(4):231-43. PubMed ID: 15144569
[TBL] [Abstract][Full Text] [Related]
34. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
[TBL] [Abstract][Full Text] [Related]
35. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.
Guerrero S; Casanova I; Farré L; Mazo A; Capellà G; Mangues R
Cancer Res; 2000 Dec; 60(23):6750-6. PubMed ID: 11118062
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of molecular chaperone 78-kd glucose-regulated protein/immunoglobulin-binding protein expression involved in enhancement of human RS cell mutability.
Hirano J; Kita K; Sugaya S; Ichimura Y; Yamamori H; Nakajima N; Suzuki N
Pancreas; 2008 Jan; 36(1):e7-14. PubMed ID: 18192872
[TBL] [Abstract][Full Text] [Related]
37. Preferential carcinogen-DNA adduct formation at codons 12 and 14 in the human K-ras gene and their possible mechanisms.
Hu W; Feng Z; Tang MS
Biochemistry; 2003 Aug; 42(33):10012-23. PubMed ID: 12924950
[TBL] [Abstract][Full Text] [Related]
38. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
[TBL] [Abstract][Full Text] [Related]
39. Piperonyl butoxide mutagenicity in human RSa cells.
Suzuki H; Suzuki N
Mutat Res; 1995 Aug; 344(1-2):27-30. PubMed ID: 7565889
[TBL] [Abstract][Full Text] [Related]
40. Purification and properties of a novel recombinant human hybrid interferon, delta-4 alpha 2/alpha 1.
Le HV; Syto R; Schwartz J; Nagabhushan TL; Trotta PP
Biochim Biophys Acta; 1988 Nov; 957(1):143-51. PubMed ID: 3052593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
